Despite the difference in parvalbumin expression in mice and humans, we were able to prove that parvalbumin suppressed M2 macrophage polarization in both mice and humans, thus targeting parvalbumin may serve as a strategy to combat against obesity in humans, which will need further evaluation. Here, PVALB is linked to obesity due to melanocortin 4 receptor deficiency.